Tokyo, Sept 20, 2006 (JCN) - GNI and its Chinese affiliate Shanghai Genomics announced September 15 that they have identified an important regulator and its associated signaling cascade in X-linked lymphoproliferative disease (XLP), a human immunological disorder.
